Tigatuzumab
Tigatuzumab Uses, Dosage, Side Effects, Food Interaction and all others data.
Tigatuzumab is under investigation in clinical trial NCT00991796 (CS-1008 With Carboplatin/Paclitaxel in Chemotherapy naïve Subjects With Metastatic or Unresectable Non-small Cell Lung Cancer (NSCLC)).
| Trade Name | Tigatuzumab |
| Generic | Tigatuzumab |
| Tigatuzumab Other Names | Tigatuzumab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Tigatuzumab
